Pro Medicus share price drops 5% despite strong FY 2020 growth

The Pro Medicus Limited (ASX:PME) share price is dropping lower on Thursday following the release of its full year results for FY 2020…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Pro Medicus Limited (ASX: PME) share price has come under pressure following its full year results release.

In morning trade the Pro Medicus share price is down almost 5% to $24.10.

How did Pro Medicus perform in FY 2020?

For the 12 months ended 30 June 2020, the leading health imaging company reported a 23.9% increase in revenue from underlying operations to $56.8 million.

Management advised that this was driven by solid growth in key jurisdictions, with North American revenue up 23.7% and Australian revenue rising 19.2%. This offset a 37.7% decline in revenue in Europe, which was largely a result of the one-off sale to the German government in the previous period.

Thanks to a lift in its margins to 52.5%, underlying profit before tax (which excludes a $3 million one-off capital sale to the German government in the previous period) was up 33.4% to $30.24 million.

On the bottom line, Pro Medicus posted a full year reported net profit of $23.1 million. This was up 20.7% on the prior corresponding period.

In light of this strong form and its very strong balance sheet (cash reserves of $43.4 million and no debt), the board declared a fully franked final dividend of 6 cents per share. This lifted its total FY 2020 dividend to 12 cents per share, up 14.3% year on year.

Management commentary.

Pro Medicus' CEO, Dr. Sam Hupert, was pleased with the company's performance in FY 2020.

He said: "It reinforces the momentum achieved in recent years. Key drivers of the profit increase were growth in transaction revenue in North America and increased RIS sales in Australia. The three key contract wins in the USA extends our growing footprint in the academic hospital segment as well as regionally-based community hospitals."

The chief executive also provided investors with an update on how COVID-19 was impacting the business. Pleasingly, while there has been some impact, it has not been substantial.

Dr. Hupert said: "We have kept momentum going operationally, and our client volumes have increased steadily after an initial steep drop in exam numbers at the end of March/beginning of April. By 30th June, average examination volumes were back above 90% of normal business levels across the USA and Australia. Compared to many other businesses, we have held up very well."

No guidance was given for FY 2021, but the chief executive notes that its pipeline remains strong and has continued to grow even during the pandemic.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Pro Medicus Ltd. The Motley Fool Australia owns shares of and has recommended Pro Medicus Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Fallers

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A worried man holds his head and look at his computer.
Share Fallers

Why 29Metals, Brainchip, Platinum, and Premier Investments shares are falling today

These ASX shares are having a tough time on hump day.

Read more »

Man with his head in his head because of falling share price.
Share Fallers

Why 29Metals, Atlas Arteria, IDP Education, and Mineral Resources shares are falling

These ASX shares are having a tough time on Tuesday. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why ALS, EOS, NRW, and Patriot Battery Metals are dropping today

These ASX shares are starting the week in the red.

Read more »

A man looking at his laptop and thinking.
Technology Shares

Why are these ASX tech shares getting smashed today?

Owners of these two stocks are missing out today.

Read more »

a man weraing a suit sits nervously at his laptop computer biting into his clenched hand with nerves, and perhaps fear.
Share Fallers

Why AGL, Brickworks, IGO, and New Hope shares are dropping today

These ASX shares are having a poor session. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Amcor, Arafura, Brainchip, and South32 shares are tumbling today

These ASX shares are having a tough time on hump day. But why?

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Aussie Broadband, Liontown, Metals Acquisition, and Seek shares are falling

These ASX shares are having a poor session. But why?

Read more »